Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 133INDUSTRY 33NIH 12OTHER_GOV 5NETWORK 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 125Gynecologic 120Gastrointestinal 119Thoracic 109Sarcoma 96Genitourinary 94Other hematologic neoplasm 91CNS 72Breast 71Head & Neck 49Plasma cell 42Dermatologic 37Myeloid 19Other solid neoplasm 14Classical hematology 8Tumor-Agnostic 7Endocrine 7Other neoplasm 6Other 3NET 2

Conditions

Neuroendocrine Tumors 2Vipoma 1Somatostatinoma 1Neoplasms 1Insulinoma 1Glucagonoma 1Gastrinoma 1Carcinoma, Islet Cell 1Adenoma, Islet Cell 1

Interventions

motesanib diphosphate 1batifiban 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × NETWORK × NET × Clear all
NCT06345079 2025-08-14

STOPNET

Australasian Gastro-Intestinal Trials Group

Phase 2 Recruiting
78 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT00427349 2023-07-05

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Eastern Cooperative Oncology Group

Phase 2 Completed
46 enrolled 7 charts
EndocrineNET

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡